The global fungal testing equipment market is on the cusp of remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 10.1% from 2023 to 2033, according to a recent report by Future Market Insights. The market is expected to achieve a valuation of USD 4,504 million by 2033, underscoring the growing significance of fungal testing in modern healthcare.
As of 2023, the market for fungal testing kits has solidified its position, surpassing USD 1,716.5 million in valuation. Diagnostic laboratories are a key driver of this growth, accounting for over 51.8% of the market share. Their dominant presence highlights the essential role that diagnostic labs play in advancing fungal testing technologies, crucial for timely and accurate diagnostics.
The rising demand for sophisticated fungal testing equipment is fueled by the increasing prevalence of fungal infections and heightened awareness of their serious health impacts. In healthcare settings, the need for precise diagnostics is more critical than ever, especially as conditions like candidiasis and invasive fungal diseases become increasingly widespread.
This rapid market expansion reflects the importance of innovations in fungal testing, enhancing diagnostic capabilities and addressing the evolving needs of the global healthcare sector. With ongoing technological advancements, the fungal testing market is poised for continued robust growth.
Regional Insights: North America and Asia-Pacific Lead the Charge:
North America currently dominates the global fungal testing kits market, driven by a high incidence of infectious diseases and growing awareness of fungal infections. The region is expected to maintain strong demand for fungal testing kits throughout the forecast period.
Meanwhile, the Asia-Pacific region is witnessing rapid growth in the fungal testing kits market, spurred by rising healthcare expenditures and a large patient population. The high prevalence of infections, particularly candidiasis and invasive fungal diseases, is driving demand for advanced fungal testing equipment, presenting significant growth opportunities.
As the global market for fungal testing equipment continues to evolve, ongoing technological advancements will further propel market growth, enabling healthcare providers to deliver more accurate and timely diagnoses for fungal infections worldwide.
Key Market Takeaways:
- The molecular test segment is projected to grow at a CAGR of 7.5% from 2023 to 2033 within the test type category.
- The diagnostic laboratory sector of the fungal testing kits industry is expected to experience a CAGR of 7.4% over the same period.
- The U.S. fungal testing equipment market is set to advance at a CAGR of 9.8%, reaching USD 1210.95 million by 2033.
- China’s fungal testing kits industry is forecasted to climb at a CAGR of 12.9%, with an estimated value of USD 488.22 million by 2033.
- The Canadian market is anticipated to expand at a CAGR of 8.4%, reaching USD 105.55 million by 2033.
- Germany’s fungal testing kits industry is expected to grow at a rapid pace, with a CAGR of 12.6% and a projected value of USD 352.17 million by 2033.
- The U.K. market is set to evolve at a CAGR of 9.8%, reaching USD 250.61 million by 2033.
Enhanced Market Demand: Discover Thorough Trends and Insights in Our Complete Report!
Strategic Innovations and Industry Collaborations:
Leading manufacturers in the fungal testing kits market, including Thermo Fisher Scientific, PerkinElmer Inc., ELITech Group, Merck KGaA, bioMerieux SA, and others, are focused on strategic partnerships, collaborations, and acquisitions to develop profitable diagnostic kits.
Notable Acquisitions:
- ELITech Group acquired the medical goods business Gonotec GmbH on July 14, 2021.
- Thermo Fisher Scientific expanded its laboratory services and product line for fungal testing equipment through its acquisition of Brammer Bio in 2019.
Market Segmentation:
By Test Type:
- Molecular Test
- Chromogenic Test
- Others
By Sample Type:
- Skin
- Urine
- Vaginal Secretions
- Blood
- Cerebral
- Others
By Application:
- Research
- Susceptibility Testing
- Medical Diagnosis
- Others
By End User:
- Diagnostic Laboratory
- Hospitals
- Pharmaceutical Companies
- Research and Academic Institutes
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
